Cleared Traditional

K130666 - KHAN KINETIC TREATMENT (KKT-M2) (FDA 510(k) Clearance)

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2014
Decision
317d
Days
-
Risk

K130666 is an FDA 510(k) clearance for the KHAN KINETIC TREATMENT (KKT-M2). Classified as Manipulator, Plunger-like Joint (product code LXM).

Submitted by Optima Health Solutions International Corporation (Vancouver, CA). The FDA issued a Cleared decision on January 23, 2014 after a review of 317 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Physical Medicine FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Optima Health Solutions International Corporation devices

Submission Details

510(k) Number K130666 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 2013
Decision Date January 23, 2014
Days to Decision 317 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
202d slower than avg
Panel avg: 115d · This submission: 317d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LXM Manipulator, Plunger-like Joint
Device Class -